| 0 |
PARANASAL SINUS HAEMATOMA |
1 |
0.0500 |
| 1 |
HEPATIC CYST INFECTION |
1 |
0.0102 |
| 2 |
SUSPECTED DRUG-INDUCED LIVER INJURY |
2 |
0.0100 |
| 3 |
RECTAL ULCER HAEMORRHAGE |
2 |
0.0080 |
| 4 |
RENAL REPLACEMENT THERAPY |
1 |
0.0078 |
| 5 |
SHUNT MALFUNCTION |
2 |
0.0071 |
| 6 |
LIMB FRACTURE |
1 |
0.0067 |
| 7 |
CENTRAL HYPOTHYROIDISM |
2 |
0.0060 |
| 8 |
ARTERIOVENOUS FISTULA SITE HAEMORRHAGE |
1 |
0.0053 |
| 9 |
SHUNT STENOSIS |
1 |
0.0036 |
| 10 |
PSEUDOSTROKE |
1 |
0.0029 |
| 11 |
DIALYSIS RELATED COMPLICATION |
1 |
0.0028 |
| 12 |
LIMB AMPUTATION |
1 |
0.0025 |
| 13 |
PERIPHERAL CIRCULATORY FAILURE |
1 |
0.0024 |
| 14 |
PERIPHERAL ARTERY ANEURYSM |
1 |
0.0024 |
| 15 |
SPINAL CORD INFARCTION |
1 |
0.0023 |
| 16 |
MARASMUS |
3 |
0.0020 |
| 17 |
SHUNT OCCLUSION |
1 |
0.0020 |
| 18 |
POOR PERSONAL HYGIENE |
1 |
0.0019 |
| 19 |
DYSMETRIA |
1 |
0.0017 |
| 20 |
INTERNAL INJURY |
1 |
0.0015 |
| 21 |
PALLIATIVE CARE |
2 |
0.0013 |
| 22 |
ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0013 |
| 23 |
ABDOMINAL SYMPTOM |
1 |
0.0012 |
| 24 |
CALCIPHYLAXIS |
2 |
0.0011 |
| 25 |
TRAUMATIC INTRACRANIAL HAEMORRHAGE |
1 |
0.0011 |
| 26 |
ELECTRIC SHOCK SENSATION |
3 |
0.0011 |
| 27 |
SPUTUM RETENTION |
1 |
0.0010 |
| 28 |
RENAL TRANSPLANT |
3 |
0.0008 |
| 29 |
MENTAL STATUS CHANGES |
23 |
0.0008 |
| 30 |
NECROTISING COLITIS |
1 |
0.0008 |
| 31 |
SLOW RESPONSE TO STIMULI |
1 |
0.0008 |
| 32 |
SLEEP PARALYSIS |
1 |
0.0007 |
| 33 |
SUPERINFECTION |
1 |
0.0007 |
| 34 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 35 |
BRADYARRHYTHMIA |
1 |
0.0006 |
| 36 |
AORTIC VALVE STENOSIS |
1 |
0.0006 |
| 37 |
SINUS NODE DYSFUNCTION |
1 |
0.0005 |
| 38 |
INTESTINAL ISCHAEMIA |
3 |
0.0005 |
| 39 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
14 |
0.0005 |
| 40 |
ALTERED STATE OF CONSCIOUSNESS |
11 |
0.0005 |
| 41 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 42 |
FLAT AFFECT |
1 |
0.0004 |
| 43 |
PUSTULE |
1 |
0.0004 |
| 44 |
DERMAL CYST |
1 |
0.0004 |
| 45 |
HYPERAMMONAEMIA |
2 |
0.0004 |
| 46 |
CORONARY ARTERY STENOSIS |
2 |
0.0004 |
| 47 |
PEMPHIGOID |
3 |
0.0004 |
| 48 |
FEMORAL NECK FRACTURE |
2 |
0.0004 |
| 49 |
PSYCHOMOTOR SKILLS IMPAIRED |
1 |
0.0004 |
| 50 |
PSYCHOMOTOR RETARDATION |
1 |
0.0004 |
| 51 |
DIALYSIS |
5 |
0.0004 |
| 52 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 53 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 54 |
STRIDOR |
1 |
0.0003 |
| 55 |
GANGRENE |
2 |
0.0003 |
| 56 |
SKIN EROSION |
1 |
0.0003 |
| 57 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 58 |
CORONAVIRUS INFECTION |
2 |
0.0003 |
| 59 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 60 |
RESPIRATION ABNORMAL |
2 |
0.0003 |
| 61 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 62 |
CUTANEOUS VASCULITIS |
1 |
0.0003 |
| 63 |
TONGUE OEDEMA |
1 |
0.0003 |
| 64 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 65 |
DISORIENTATION |
10 |
0.0003 |
| 66 |
CEREBRAL INFARCTION |
6 |
0.0002 |
| 67 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 68 |
EOSINOPHIL COUNT INCREASED |
2 |
0.0002 |
| 69 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 70 |
WHEELCHAIR USER |
1 |
0.0002 |
| 71 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 72 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 73 |
HALLUCINATION |
16 |
0.0002 |
| 74 |
SKIN ABRASION |
1 |
0.0002 |
| 75 |
FRACTURE |
4 |
0.0002 |
| 76 |
BLOOD PRESSURE DECREASED |
14 |
0.0002 |
| 77 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 78 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 79 |
DELIRIUM |
7 |
0.0002 |
| 80 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 81 |
SOMNOLENCE |
40 |
0.0002 |
| 82 |
HYPOTHERMIA |
2 |
0.0002 |
| 83 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 84 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 85 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 86 |
BRAIN FOG |
3 |
0.0002 |
| 87 |
HALLUCINATION, VISUAL |
4 |
0.0002 |
| 88 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 89 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 90 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 91 |
IMPAIRED DRIVING ABILITY |
2 |
0.0002 |
| 92 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 93 |
DRUG ERUPTION |
3 |
0.0002 |
| 94 |
LOCALISED INFECTION |
4 |
0.0002 |
| 95 |
PNEUMONIA ASPIRATION |
4 |
0.0002 |
| 96 |
PHOTOPSIA |
1 |
0.0002 |
| 97 |
SCREAMING |
1 |
0.0002 |
| 98 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 99 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 100 |
SOMNAMBULISM |
1 |
0.0002 |
| 101 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 102 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 103 |
HYPERKALAEMIA |
5 |
0.0001 |
| 104 |
SKIN HAEMORRHAGE |
2 |
0.0001 |
| 105 |
CONCUSSION |
1 |
0.0001 |
| 106 |
PELVIC FRACTURE |
1 |
0.0001 |
| 107 |
SENSORY DISTURBANCE |
2 |
0.0001 |
| 108 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 109 |
ASPHYXIA |
1 |
0.0001 |
| 110 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 111 |
FACE OEDEMA |
2 |
0.0001 |
| 112 |
CONFUSIONAL STATE |
19 |
0.0001 |
| 113 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 114 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 115 |
DEMENTIA |
3 |
0.0001 |
| 116 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 117 |
COGNITIVE DISORDER |
5 |
0.0001 |
| 118 |
DYSARTHRIA |
4 |
0.0001 |
| 119 |
FALL |
35 |
0.0001 |
| 120 |
LETHARGY |
6 |
0.0001 |
| 121 |
HEPATIC FAILURE |
3 |
0.0001 |
| 122 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 123 |
EAR DISCOMFORT |
1 |
0.0001 |
| 124 |
SUDDEN DEATH |
1 |
0.0001 |
| 125 |
HIP FRACTURE |
3 |
0.0001 |
| 126 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 127 |
DIZZINESS |
45 |
0.0001 |
| 128 |
SKIN INFECTION |
1 |
0.0001 |
| 129 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 130 |
BACTERAEMIA |
1 |
0.0001 |
| 131 |
CHOLECYSTITIS |
1 |
0.0001 |
| 132 |
MYOCLONUS |
1 |
0.0001 |
| 133 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 134 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 135 |
PEMPHIGUS |
1 |
0.0001 |
| 136 |
THERAPY CESSATION |
4 |
0.0001 |
| 137 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 138 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 139 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 140 |
ROAD TRAFFIC ACCIDENT |
3 |
0.0001 |
| 141 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 142 |
ANGINA PECTORIS |
2 |
0.0001 |
| 143 |
HYPERSOMNIA |
2 |
0.0001 |
| 144 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 145 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 146 |
ACUTE MYOCARDIAL INFARCTION |
2 |
0.0001 |
| 147 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 148 |
EPILEPSY |
2 |
0.0001 |
| 149 |
ANKLE FRACTURE |
1 |
0.0001 |
| 150 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 151 |
SICKLE CELL ANAEMIA WITH CRISIS |
1 |
0.0001 |
| 152 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 153 |
LOSS OF CONSCIOUSNESS |
8 |
0.0001 |
| 154 |
AMNESIA |
4 |
0.0001 |
| 155 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 156 |
PARANOIA |
1 |
0.0001 |
| 157 |
BALANCE DISORDER |
5 |
0.0001 |
| 158 |
NIGHTMARE |
2 |
0.0001 |
| 159 |
GAIT DISTURBANCE |
11 |
0.0001 |
| 160 |
EOSINOPHILIA |
1 |
0.0001 |
| 161 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
0.0001 |
| 162 |
GOUT |
1 |
0.0001 |
| 163 |
OSTEOMYELITIS |
1 |
0.0001 |
| 164 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 165 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 166 |
HYPOTENSION |
11 |
0.0001 |
| 167 |
RESTLESSNESS |
2 |
0.0001 |
| 168 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 169 |
FOOT FRACTURE |
1 |
0.0001 |
| 170 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 171 |
DYSTONIA |
1 |
0.0001 |
| 172 |
CHOKING |
1 |
0.0001 |
| 173 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 174 |
CARDIAC FAILURE |
4 |
0.0000 |
| 175 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 176 |
VERTIGO |
3 |
0.0000 |
| 177 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 178 |
ASTHENIA |
18 |
0.0000 |
| 179 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 180 |
SEPTIC SHOCK |
2 |
0.0000 |
| 181 |
MELAENA |
1 |
0.0000 |
| 182 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 183 |
PRURITUS |
17 |
0.0000 |
| 184 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 185 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 186 |
SHOCK |
1 |
0.0000 |
| 187 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 188 |
PALPITATIONS |
5 |
0.0000 |
| 189 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 190 |
CONTUSION |
4 |
0.0000 |
| 191 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 192 |
AGITATION |
3 |
0.0000 |
| 193 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 194 |
HAEMATEMESIS |
1 |
0.0000 |
| 195 |
NERVOUSNESS |
2 |
0.0000 |
| 196 |
BRADYCARDIA |
2 |
0.0000 |
| 197 |
SKIN LESION |
1 |
0.0000 |
| 198 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 199 |
SEPSIS |
4 |
0.0000 |
| 200 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 201 |
DEATH |
30 |
0.0000 |
| 202 |
SEIZURE |
4 |
0.0000 |
| 203 |
GENERAL PHYSICAL HEALTH DETERIORATION |
4 |
0.0000 |
| 204 |
DYSSTASIA |
1 |
0.0000 |
| 205 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 206 |
APHASIA |
1 |
0.0000 |
| 207 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 208 |
FEMUR FRACTURE |
1 |
0.0000 |
| 209 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 210 |
HEAD INJURY |
1 |
0.0000 |
| 211 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 212 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 213 |
SYNCOPE |
3 |
0.0000 |
| 214 |
SKIN DISORDER |
1 |
0.0000 |
| 215 |
URINARY RETENTION |
1 |
0.0000 |
| 216 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 217 |
HYPOXIA |
1 |
0.0000 |
| 218 |
INFECTION |
4 |
0.0000 |
| 219 |
UNDERDOSE |
2 |
0.0000 |
| 220 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 221 |
EYE SWELLING |
1 |
0.0000 |
| 222 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 223 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 224 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 225 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 226 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 227 |
HOSPITALISATION |
4 |
0.0000 |
| 228 |
PARAESTHESIA |
4 |
0.0000 |
| 229 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 230 |
OSTEOPOROSIS |
1 |
0.0000 |
| 231 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 232 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 233 |
MENTAL DISORDER |
1 |
0.0000 |
| 234 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 235 |
NAUSEA |
18 |
0.0000 |
| 236 |
ANGIOEDEMA |
1 |
0.0000 |
| 237 |
LIVER DISORDER |
1 |
0.0000 |
| 238 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 239 |
THROAT IRRITATION |
1 |
0.0000 |
| 240 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 241 |
PNEUMONIA |
7 |
0.0000 |
| 242 |
ARRHYTHMIA |
1 |
0.0000 |
| 243 |
DYSPHAGIA |
2 |
0.0000 |
| 244 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 245 |
COMA |
1 |
0.0000 |
| 246 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 247 |
LUNG DISORDER |
1 |
0.0000 |
| 248 |
AGGRESSION |
1 |
0.0000 |
| 249 |
CELLULITIS |
1 |
0.0000 |
| 250 |
FLUSHING |
2 |
0.0000 |
| 251 |
OFF LABEL USE |
17 |
0.0000 |
| 252 |
INFLAMMATION |
1 |
0.0000 |
| 253 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 254 |
VOMITING |
9 |
0.0000 |
| 255 |
HAEMORRHAGE |
2 |
0.0000 |
| 256 |
DRUG INTERACTION |
3 |
0.0000 |
| 257 |
INSOMNIA |
5 |
0.0000 |
| 258 |
RASH PRURITIC |
1 |
0.0000 |
| 259 |
OEDEMA |
1 |
0.0000 |
| 260 |
DRUG INEFFECTIVE |
24 |
0.0000 |
| 261 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 262 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 263 |
DYSPNOEA |
10 |
0.0000 |
| 264 |
FLATULENCE |
1 |
0.0000 |
| 265 |
DECREASED APPETITE |
4 |
0.0000 |
| 266 |
BACK PAIN |
4 |
0.0000 |
| 267 |
WHEEZING |
1 |
0.0000 |
| 268 |
IRRITABILITY |
1 |
0.0000 |
| 269 |
FEELING HOT |
1 |
0.0000 |
| 270 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 271 |
CHEST PAIN |
3 |
0.0000 |
| 272 |
SWELLING FACE |
1 |
0.0000 |
| 273 |
BURNING SENSATION |
1 |
0.0000 |
| 274 |
SLEEP DISORDER |
1 |
0.0000 |
| 275 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 276 |
DIARRHOEA |
9 |
0.0000 |
| 277 |
MOBILITY DECREASED |
1 |
0.0000 |
| 278 |
HOT FLUSH |
1 |
0.0000 |
| 279 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 280 |
DIABETES MELLITUS |
1 |
0.0000 |
| 281 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 282 |
FATIGUE |
10 |
0.0000 |
| 283 |
FEELING ABNORMAL |
3 |
0.0000 |
| 284 |
TREMOR |
2 |
0.0000 |
| 285 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 286 |
HEADACHE |
7 |
0.0000 |
| 287 |
ADVERSE EVENT |
1 |
0.0000 |
| 288 |
CARDIAC DISORDER |
1 |
0.0000 |
| 289 |
SWELLING |
1 |
0.0000 |
| 290 |
MIGRAINE |
1 |
0.0000 |
| 291 |
HEART RATE INCREASED |
1 |
0.0000 |
| 292 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 293 |
PAIN |
6 |
0.0000 |
| 294 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 295 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 296 |
ILLNESS |
1 |
0.0000 |
| 297 |
OVERDOSE |
2 |
0.0000 |
| 298 |
RASH |
4 |
0.0000 |
| 299 |
INFLUENZA |
1 |
0.0000 |
| 300 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 301 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 302 |
JOINT SWELLING |
1 |
0.0000 |
| 303 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 304 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 305 |
RENAL FAILURE |
1 |
0.0000 |
| 306 |
DEHYDRATION |
1 |
0.0000 |
| 307 |
DRY SKIN |
1 |
0.0000 |
| 308 |
WEIGHT DECREASED |
2 |
0.0000 |
| 309 |
COUGH |
2 |
0.0000 |
| 310 |
ANXIETY |
2 |
0.0000 |
| 311 |
MALAISE |
3 |
0.0000 |
| 312 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 313 |
HYPOAESTHESIA |
1 |
0.0000 |
| 314 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 315 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 316 |
MYALGIA |
1 |
0.0000 |
| 317 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 318 |
PYREXIA |
2 |
0.0000 |
| 319 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 320 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 321 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 322 |
ERYTHEMA |
1 |
0.0000 |
| 323 |
HYPERTENSION |
1 |
0.0000 |
| 324 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 325 |
ARTHRALGIA |
1 |
0.0000 |